Loading institutional data...
Loading institutional data...
Held by 1,070 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $85.18 today, the market must believe free cash flow compounds 5.5%/yr for a decade (off $2.8B normalized FCF).
The market's 5.5% is more optimistic than its 4-yr track record.
2-stage DCF · 0.48B shares · net debt $6.4B
mean 40.3% · volatility σ 142% · implied rate exceeded in 2/4 yrs
Central path = implied 5.5%/yr growth; shaded band = ±1σ (142%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-18
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.27B 100.0% | $85.53B 100.0% | $93.94B 100.0% | $101.56B 100.0% | $85.25B 100.0% | $64.36B 100.0% | $64.66B 100.0% | $64.34B 100.0% | $60.83B 100.0% | $62.35B 100.0% |
| Cost of Revenue | $75.24B 93.7% | $79.75B 93.2% | $86.42B 92.0% | $93.99B 92.5% | $79.26B 93.0% | $59.90B 93.1% | $60.51B 93.6% | $60.16B 93.5% | $57.31B 94.2% | $58.73B 94.2% |
| Gross Profit | $5.03B 6.3% | $5.78B 6.8% | $7.51B 8.0% | $7.57B 7.5% | $5.99B 7.0% | $4.45B 6.9% | $4.15B 6.4% | $4.18B 6.5% | $3.52B 5.8% | $3.62B 5.8% |
| Research & Development | $246.0M 0.3% | $269.0M 0.3% | $256.0M 0.3% | $216.0M 0.2% | $171.0M 0.2% | $160.0M 0.2% | $154.0M 0.2% | $141.0M 0.2% | $129.0M 0.2% | $123.0M 0.2% |
| Selling, General & Admin | $3.61B 4.5% | $3.71B 4.3% | $3.46B 3.7% | $3.36B 3.3% | $2.99B 3.5% | $2.69B 4.2% | $2.49B 3.9% | $2.17B 3.4% | $1.98B 3.3% | $1.98B 3.2% |
| Interest Expense | $612.0M 0.8% | $706.0M 0.8% | $647.0M 0.7% | $396.0M 0.4% | $265.0M 0.3% | $339.0M 0.5% | $402.0M 0.6% | $364.0M 0.6% | $330.0M 0.5% | $293.0M 0.5% |
| Other Income (Expense), net | $150.0M 0.2% | $251.0M 0.3% | $176.0M 0.2% | $358.0M 0.4% | $94.0M 0.1% | $255.0M 0.4% | -$7.0M -0.0% | -$101.0M -0.2% | $10.0M 0.0% | $149.0M 0.2% |
| Pretax Income | $1.25B 1.6% | $2.25B 2.6% | $4.29B 4.6% | $5.23B 5.2% | $3.31B 3.9% | $1.88B 2.9% | $1.59B 2.5% | $2.06B 3.2% | $1.61B 2.6% | $1.82B 2.9% |
| Income Tax Expense | $182.0M 0.2% | $476.0M 0.6% | $828.0M 0.9% | $868.0M 0.9% | $578.0M 0.7% | $101.0M 0.2% | $209.0M 0.3% | $245.0M 0.4% | $7.0M 0.0% | $534.0M 0.9% |
| Net Income | $1.08B 1.3% | $1.80B 2.1% | $3.48B 3.7% | $4.34B 4.3% | $2.71B 3.2% | $1.77B 2.8% | $1.38B 2.1% | $1.81B 2.8% | $1.59B 2.6% | $1.28B 2.1% |
| Per Share | ||||||||||
| EPS (Basic) | $2.23 | $3.66 | $6.44 | $7.72 | $4.80 | $3.16 | $2.45 | $3.21 | $2.80 | $2.18 |
| EPS (Diluted) | $2.23 | $3.65 | $6.43 | $7.71 | $4.79 | $3.15 | $2.44 | $3.19 | $2.79 | $2.16 |
| Weighted Avg Shares (Basic) | 484.0M | 492.0M | 541.0M | 562.0M | 564.0M | 561.0M | 563.0M | 564.0M | 569.0M | 588.0M |
| Weighted Avg Shares (Diluted) | 484.0M | 493.0M | 542.0M | 563.0M | 566.0M | 565.0M | 565.0M | 567.0M | 572.0M | 591.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 23% of free cash flow, leaving room to grow it and fund buybacks. Last year: $987M dividends + $0 buybacks = $987M returned on $4.2B FCF.
9 consecutive years of dividend increases · 6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Insufficient data. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-09-18
No material risks flagged.
Where each multiple sits in its own 15-yr range · 98th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 93.5 | 93.6 | 93.1 | 93.0 | 92.5 | 92.0 | 93.2 | 93.7 |
| Gross Profit | 6.5 | 6.4 | 6.9 | 7.0 | 7.5 | 8.0 | 6.8 | 6.3 |
| R&D | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 |
| SG&A | 3.4 | 3.9 | 4.2 | 3.5 | 3.3 | 3.7 | 4.3 | 4.5 |
| Income Tax | 0.4 | 0.3 | 0.2 | 0.7 | 0.9 | 0.9 | 0.6 | 0.2 |
| Net Income | 2.8 | 2.1 | 2.8 | 3.2 | 4.3 | 3.7 | 2.1 | 1.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ADM: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $1.0B covers the $1.0B due within a year 1.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~8.3% on $7.4B of debt.
Cash of $1.0B fully covers short-term debt of $798M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.0B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.8B | 49.2× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $379.7B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $344.0B | 22.5× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $293.5B | 26.0× | 17.1× | 7.2× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $177.6B | 21.6× | 14.6× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.4B | 16.9× | 13.5× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $78.7B | 32.2× | 18.5× | 2.0× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $71.6B | 19.5× | 10.4× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.1B | 33.3× | 19.5× | 3.4× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.7B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.1B | 20.2× | 14.2× | 2.5× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $41.2B | 38.2× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $40.4B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.3B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.1B | 39.0× | 9.9× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| HSY | $34.4B | — | 20.2× | 3.0× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| KVUE | $34.1B | 23.4× | 11.6× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| EL | $33.6B | — | 764.7× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.5B | 16.1× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $28.9B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.0B | 17.9× | 7.9× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.1B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.0B | 31.4× | 18.7× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
Peers = companies sharing ADM's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.